14.77
price down icon20.63%   -3.84
after-market Handel nachbörslich: 14.89 0.12 +0.81%
loading
Schlusskurs vom Vortag:
$18.61
Offen:
$17.75
24-Stunden-Volumen:
2.55M
Relative Volume:
3.73
Marktkapitalisierung:
$1.90B
Einnahmen:
$628.25M
Nettoeinkommen (Verlust:
$-78.55M
KGV:
-23.82
EPS:
-0.62
Netto-Cashflow:
$-29.73M
1W Leistung:
-13.02%
1M Leistung:
-19.86%
6M Leistung:
+9.25%
1J Leistung:
-7.51%
1-Tages-Spanne:
Value
$14.51
$17.75
1-Wochen-Bereich:
Value
$14.51
$19.11
52-Wochen-Spanne:
Value
$12.77
$19.11

Neogenomics Inc Stock (NEO) Company Profile

Name
Firmenname
Neogenomics Inc
Name
Telefon
(239) 768-0600
Name
Adresse
9490 NEOGENOMICS WAY, FORT MYERS, FL
Name
Mitarbeiter
2,100
Name
Twitter
@NeoGenomics
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
NEO's Discussions on Twitter

Vergleichen Sie NEO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
NEO
Neogenomics Inc
14.77 1.90B 628.25M -78.55M -29.73M -0.62
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
542.31 207.43B 42.37B 6.14B 7.78B 15.95
Diagnostics & Research icon
DHR
Danaher Corp
235.07 169.79B 23.74B 3.89B 4.98B 5.24
Diagnostics & Research icon
A
Agilent Technologies Inc
137.47 39.26B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
203.27 36.89B 15.32B 1.41B 1.96B 7.62
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
418.05 34.23B 3.84B 866.24M 792.60M 10.37

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-10 Eingeleitet Jefferies Buy
2024-05-01 Fortgesetzt Craig Hallum Buy
2023-12-29 Bestätigt BTIG Research Buy
2023-08-21 Hochstufung Stephens Equal-Weight → Overweight
2023-05-16 Herabstufung Raymond James Outperform → Mkt Perform
2023-05-09 Hochstufung BTIG Research Neutral → Buy
2023-02-24 Hochstufung The Benchmark Company Hold → Buy
2023-02-01 Hochstufung Needham Hold → Buy
2022-08-26 Herabstufung The Benchmark Company Buy → Hold
2022-08-22 Herabstufung Needham Buy → Hold
2022-06-03 Eingeleitet Piper Sandler Overweight
2022-03-29 Herabstufung BofA Securities Buy → Neutral
2022-03-29 Herabstufung Stephens Overweight → Equal-Weight
2022-01-18 Fortgesetzt Stephens Overweight
2021-12-16 Eingeleitet Cowen Outperform
2021-11-05 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-10-14 Hochstufung Raymond James Mkt Perform → Outperform
2021-06-03 Eingeleitet Goldman Buy
2021-02-25 Fortgesetzt Needham Buy
2021-02-25 Herabstufung Raymond James Outperform → Mkt Perform
2021-01-28 Eingeleitet Truist Buy
2020-12-11 Fortgesetzt BTIG Research Buy
2020-10-28 Bestätigt Needham Buy
2020-09-09 Eingeleitet Morgan Stanley Overweight
2020-08-28 Eingeleitet Guggenheim Buy
2020-07-29 Bestätigt Needham Buy
2020-06-25 Eingeleitet BofA/Merrill Buy
2020-04-21 Fortgesetzt Stephens Overweight
2020-03-02 Fortgesetzt Craig Hallum Buy
2020-02-28 Hochstufung First Analysis Sec Outperform → Strong Buy
2020-01-23 Herabstufung First Analysis Sec Strong Buy → Outperform
2019-10-30 Bestätigt Needham Buy
2019-05-01 Bestätigt Needham Buy
2019-03-29 Bestätigt Needham Buy
2019-01-03 Eingeleitet Needham Buy
2018-10-24 Hochstufung First Analysis Sec Outperform → Strong Buy
2018-08-21 Eingeleitet Leerink Partners Outperform
2018-05-02 Herabstufung First Analysis Sec Overweight → Equal-Weight
2017-09-11 Herabstufung BTIG Research Buy → Neutral
2017-08-24 Eingeleitet Gabelli & Co Buy
2016-12-15 Eingeleitet Cantor Fitzgerald Overweight
Alle ansehen

Neogenomics Inc Aktie (NEO) Neueste Nachrichten

pulisher
08:47 AM

NeoGenomics announces CEO succession plan - Gulfshore Business

08:47 AM
pulisher
01:55 AM

NeoGenomics Shares Fall on CEO's Plan to Retire - MarketWatch

01:55 AM
pulisher
01:48 AM

NeoGenomics' (NEO) Buy Rating Reiterated at Needham & Company LLC - MarketBeat

01:48 AM
pulisher
01:46 AM

NeoGenomics (NEO) Shares Cross Below 200 DMA - Nasdaq

01:46 AM
pulisher
01:00 AM

NeoGenomics Shares Are Falling Today: What's Going On? - Benzinga

01:00 AM
pulisher
11:58 AM

NeoGenomics (NASDAQ:NEO) Shares Gap DownTime to Sell? - MarketBeat

11:58 AM
pulisher
11:38 AM

NeoGenomics CEO steps down, shares fall 17% By Investing.com - Investing.com Canada

11:38 AM
pulisher
10:23 AM

NeoGenomics (NASDAQ:NEO) Releases FY 2024 Earnings Guidance - MarketBeat

10:23 AM
pulisher
09:23 AM

NeoGenomics (NEO) CEO Chris Smith to retire - StreetInsider.com

09:23 AM
pulisher
08:34 AM

NeoGenomics, Inc. Reaffirms Earnings Guidance for Full Year Ended December 31, 2024 - Marketscreener.com

08:34 AM
pulisher
07:57 AM

NeoGenomics Appoints Tony Zook As CEO - citybiz

07:57 AM
pulisher
07:51 AM

NeoGenomics CEO Chris Smith to Retire; Tony Zook to Take Helm - MarketWatch

07:51 AM
pulisher
07:34 AM

NeoGenomics Announces CEO Transition and Leadership Change - TipRanks

07:34 AM
pulisher
07:06 AM

NeoGenomics Announces Chief Executive Officer Succession - The Bakersfield Californian

07:06 AM
pulisher
07:05 AM

Neogenomics, Announces Retirement of Chris Smith as Board Member, Effective April 1, 2025 - Marketscreener.com

07:05 AM
pulisher
Jan 09, 2025

Leerink Partnrs Weighs in on NeoGenomics FY2024 Earnings - MarketBeat

Jan 09, 2025
pulisher
Jan 09, 2025

NeoGenomics (NASDAQ:NEO) Sets New 12-Month HighShould You Buy? - MarketBeat

Jan 09, 2025
pulisher
Jan 08, 2025

NeoGenomics stock hits 52-week high at $19.01 amid growth By Investing.com - Investing.com South Africa

Jan 08, 2025
pulisher
Jan 08, 2025

NeoGenomics stock hits 52-week high at $19.01 amid growth - Investing.com

Jan 08, 2025
pulisher
Jan 06, 2025

NeoGenomics CEO to Present Strategic Vision at J.P. Morgan Healthcare Conference - StockTitan

Jan 06, 2025
pulisher
Jan 06, 2025

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Bakersfield Californian

Jan 06, 2025
pulisher
Dec 31, 2024

NeoGenomics (NEO) Upgraded to Buy: Here's Why - MSN

Dec 31, 2024
pulisher
Dec 29, 2024

The past three years for NeoGenomics (NASDAQ:NEO) investors has not been profitable - Simply Wall St

Dec 29, 2024
pulisher
Dec 27, 2024

IBD Rating Upgrades: NeoGenomics Flashes Improved Price Strength - MSN

Dec 27, 2024
pulisher
Dec 25, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 25, 2024
pulisher
Dec 24, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Shares Acquired by Geode Capital Management LLC - MarketBeat

Dec 24, 2024
pulisher
Dec 19, 2024

Franklin Resources Inc. Has $28.23 Million Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Dec 19, 2024
pulisher
Dec 18, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Shares Bought by State Street Corp - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Natera expands lawsuit against NeoGenomics over RaDaR test By Investing.com - Investing.com Canada

Dec 18, 2024
pulisher
Dec 17, 2024

Natera expands lawsuit against NeoGenomics over RaDaR test - Investing.com India

Dec 17, 2024
pulisher
Dec 17, 2024

Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics - Business Wire

Dec 17, 2024
pulisher
Dec 15, 2024

Bank of America Raises NeoGenomics (NASDAQ:NEO) Price Target to $19.00 - Defense World

Dec 15, 2024
pulisher
Dec 11, 2024

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma - BioSpace

Dec 11, 2024
pulisher
Dec 11, 2024

BNP Paribas Financial Markets Boosts Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Dec 11, 2024
pulisher
Dec 11, 2024

NeoGenomics' Breakthrough Study Shows Promise in Early Melanoma Detection Using RaDaR® Technology - StockTitan

Dec 11, 2024
pulisher
Dec 10, 2024

Evaluating NeoGenomics: Insights From 4 Financial Analysts - Benzinga

Dec 10, 2024
pulisher
Dec 10, 2024

NeoGenomics Getting Closer To Key Technical Measure - MSN

Dec 10, 2024
pulisher
Dec 09, 2024

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting - Business Wire

Dec 09, 2024
pulisher
Dec 08, 2024

Charles Schwab Investment Management Inc. Acquires 57,677 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Dec 08, 2024
pulisher
Dec 07, 2024

NeoGenomics Inc (NEO) Trading 4.33% Higher on Dec 6 - GuruFocus.com

Dec 07, 2024
pulisher
Dec 06, 2024

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research - The Cancer Letter

Dec 06, 2024
pulisher
Dec 06, 2024

Edgestream Partners L.P. Sells 94,791 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Dec 06, 2024
pulisher
Dec 05, 2024

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research - Business Wire

Dec 05, 2024
pulisher
Dec 05, 2024

ConcertAI, NeoGenomics Launch Groundbreaking 370,000-Patient Hematology Research Platform - StockTitan

Dec 05, 2024
pulisher
Dec 01, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Shares Purchased by Bellevue Group AG - MarketBeat

Dec 01, 2024
pulisher
Nov 30, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Nov 30, 2024
pulisher
Nov 29, 2024

Mutual of America Capital Management LLC Sells 1,716 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Nov 29, 2024
pulisher
Nov 29, 2024

Algert Global LLC Has $1.18 Million Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Natixis Advisors LLC Buys 11,936 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Nov 29, 2024
pulisher
Nov 27, 2024

Loomis Sayles & Co. L P Purchases Shares of 1,207,290 NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Nov 27, 2024
pulisher
Nov 24, 2024

(NEO) Investment Analysis - Stock Traders Daily

Nov 24, 2024

Finanzdaten der Neogenomics Inc-Aktie (NEO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research LH
$232.00
price down icon 0.99%
$136.69
price down icon 2.14%
diagnostics_research WAT
$380.35
price up icon 1.64%
$175.00
price down icon 0.91%
diagnostics_research MTD
$1,210.99
price down icon 2.85%
$418.05
price down icon 3.31%
Kapitalisierung:     |  Volumen (24h):